PARAMETRIC PORTFOLIO ASSOCIATES LLC - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 129 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$442,000
-34.9%
123,167
-9.5%
0.00%
Q4 2021$679,000
-27.9%
136,064
+3.4%
0.00%
-100.0%
Q3 2021$942,000
-34.3%
131,545
-14.9%
0.00%0.0%
Q2 2021$1,433,000
+13.6%
154,560
+13.8%
0.00%0.0%
Q1 2021$1,261,000
+27.4%
135,846
+21.4%
0.00%0.0%
Q4 2020$990,000
-34.0%
111,878
-13.5%
0.00%0.0%
Q3 2020$1,501,000
-64.1%
129,354
-16.6%
0.00%
-66.7%
Q2 2020$4,182,000
+363.1%
155,190
+27.8%
0.00%
+200.0%
Q1 2020$903,000
+124.1%
121,392
-0.7%
0.00%
Q4 2019$403,000
+205.3%
122,200
+90.2%
0.00%
Q3 2019$132,000
+29.4%
64,262
+85.6%
0.00%
Q2 2019$102,000
+37.8%
34,632
+73.8%
0.00%
Q1 2019$74,000
+23.3%
19,924
+33.3%
0.00%
Q4 2018$60,000
-9.1%
14,944
+26.6%
0.00%
Q3 2018$66,000
-32.7%
11,805
-52.9%
0.00%
Q2 2018$98,000
-90.1%
25,038
-88.0%
0.00%
-100.0%
Q1 2018$986,000
+6.1%
209,445
-6.9%
0.00%0.0%
Q4 2017$929,000
-22.5%
225,005
+19.1%
0.00%0.0%
Q3 2017$1,198,000
+514.4%
188,908
+800.9%
0.00%
Q3 2016$195,000
-67.4%
20,969
-67.7%
0.00%
-100.0%
Q2 2016$599,000
+487.3%
64,868
+267.8%
0.00%
Q3 2015$102,000
-35.0%
17,636
-8.1%
0.00%
Q2 2015$157,000
-40.5%
19,188
-33.3%
0.00%
-100.0%
Q4 2014$264,000
-10.2%
28,784
-3.6%
0.00%0.0%
Q3 2014$294,000
-2.6%
29,844
+6.7%
0.00%0.0%
Q2 2014$302,00027,9600.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Defender Capital, LLC. 648,800$1,920,0001.55%
Round Table Services, LLC 339,391$998,0000.31%
ARK Investment Management 3,955,017$11,628,0000.29%
Nikko Asset Management Americas, Inc. 4,884,100$14,359,0000.28%
WASATCH ADVISORS LP 6,735,726$19,803,0000.19%
Cedar Brook Financial Partners, LLC 41,500$122,0000.06%
Unified Trust Company, N.A. 15,716$46,0000.03%
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors 13,500$40,0000.03%
STONERIDGE INVESTMENT PARTNERS LLC 16,914$50,0000.02%
Sumitomo Mitsui Trust Holdings, Inc. 4,884,100$14,359,0000.01%
View complete list of INOVIO PHARMACEUTICALS INC shareholders